Cerebral blood flow in the ventromedial prefrontal cortex correlates with treatment response to low-frequency right prefrontal repetitive transcranial magnetic stimulation in the treatment of depression

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 2, 2012, Pages 138-145

  Kito, Shinsuke ^a   Hasegawa, Takashi ^a   Koga, Yoshihiko ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral blood flow (CBF); depression; dorsolateral prefrontal cortex (DLPFC); repetitive transcranial magnetic stimulation (rTMS); ventromedial prefrontal cortex (VMPFC)

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; HUMAN; MALE; ORBITAL CORTEX; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE;

ADULT; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84857583342     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2011.02312.x     Document Type: Article

References (26)

1. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J,. Transcranial magnetic stimulation in the treatment of depression: A double-blind, placebocontrolled trial. Arch. Gen. Psychiatry 2003; 60: 1002-1008. (Pubitemid 37222083)
2. Avery DH, Holtzheimer PE III, Fawaz W, et al,. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol. Psychiatry 2006; 59: 187-194. (Pubitemid 43117509)
3. O'Reardon JP, Solvason HB, Janicak PG, et al,. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol. Psychiatry 2007; 62: 1208-1216. (Pubitemid 350060890)
4. George MS, Lisanby SH, Avery D, et al,. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Arch. Gen. Psychiatry 2010; 67: 507-516.
5. Klein E, Kreinin I, Chistyakov A, et al,. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: A double-blind controlled study. Arch. Gen. Psychiatry 1999; 56: 315-320. (Pubitemid 29165174)
6. Kauffmann CD, Cheema MA, Miller BE,. Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: A doubleblind, placebo-controlled study. Depress. Anxiety 2004; 19: 59-62. (Pubitemid 38294610)
7. Isenberg K, Downs D, Pierce K, et al,. Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. Ann. Clin. Psychiatry 2005; 17: 153-159. (Pubitemid 41176802)
8. Fitzgerald PB, Huntsman S, Gunewardene R, Kulkarni J, Daskalakis ZJ,. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int. J. Neuropsychopharmacol. 2006; 9: 655-666. (Pubitemid 46122766)
9. Stern WM, Tormos JM, Press DZ, Pearlman C, Pascual-Leone A,. Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: A double-blind, randomized, placebo-controlled trial. J. Neuropsychiatry Clin. Neurosci. 2007; 19: 179-186. (Pubitemid 46649642)
10. Fitzgerald PB, Hoy K, Daskalakis ZJ, Kulkarni J,. A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress. Anxiety 2009; 26: 229-234.
11. Wassermann EM,. Risk and safety of repetitive transcranial magnetic stimulation: Report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr. Clin. Neurophysiol. 1998; 108: 1-16.
12. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 2009; 120: 2008-2039.
13. Speer AM, Kimbrell TA, Wassermann EM, et al,. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol. Psychiatry 2000; 48: 1133-1141. (Pubitemid 32008437)
14. Kito S, Fujita K, Koga Y,. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression. Neuropsychobiology 2008; 58: 29-36.
15. Kito S, Hasegawa T, Koga Y,. Neuroanatomical correlates of therapeutic efficacy of low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression. Psychiatry Clin. Neurosci. 2011; 65: 175-182.
16. 99mTc-ECD SPET. Eur. J. Nucl. Med. Mol. Imaging 2002; 29: 331-341. (Pubitemid 34253244)
17. Takeuchi R, Yonekura Y, Takeda SK, Fujita K, Konishi J,. Fully automated quantification of regional cerebral blood flow with three-dimensional stereotaxic region of interest template: Validation using magnetic resonance imaging-technical note. Neurol. Med. Chir. (Tokyo) 2003; 43: 153-162. (Pubitemid 36417592)
18. Takeuchi R, Sengoku T, Matsumura K,. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat. Med. 2006; 24: 538-544. (Pubitemid 351194424)
19. Kito S, Fujita K, Koga Y,. Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J. Neuropsychiatry Clin. Neurosci. 2008; 20: 74-80. (Pubitemid 351295031)
20. Hamilton M,. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56-62.
21. Ebmeier KP, Donaghey C, Steele JD,. Recent developments and current controversies in depression. Lancet 2006; 367: 153-167. (Pubitemid 43077130)
22. Ressler KJ, Mayberg HS,. Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nat. Neurosci. 2007; 10: 1116-1124. (Pubitemid 47339944)
23. Drevets WC, Price JL, Furey ML,. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct. Funct. 2008; 213: 93-118.
24. Mayberg HS, Lozano AM, Voon V, et al,. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-660. (Pubitemid 40320700)
25. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH,. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 2008; 64: 461-467.
26. Dougherty DD, Weiss AP, Cosgrove GR, et al,. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J. Neurosurg. 2003; 99: 1010-1017. (Pubitemid 44717397)